β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1

Glioma is the most frequent primary central nervous system tumor. Although the current first‐line medicine, temozolomide (TMZ), promotes patient survival, drug resistance develops easily. Thus, it is important to investigate novel therapeutic reagents to solidify the treatment effect. β‐Elemene (bEL...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Hai‐bin, Wang, Jing, Jiang, Hao‐ran, Mei, Xin, Zhao, Yi‐ying, Chen, Fu‐rong, Qu, Yue, Sai, Ke, Guo, Cheng‐cheng, Yang, Qun‐ying, Zhang, Zong‐ping, Chen, Zhong‐ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442766/
https://www.ncbi.nlm.nih.gov/pubmed/28297578
http://dx.doi.org/10.5966/sctm.2016-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442766/
https://www.ncbi.nlm.nih.gov/pubmed/28297578
http://dx.doi.org/10.5966/sctm.2016-0009

Ejemplares similares